The indication for its use in Crohn's disease is exciting, but let's not get ahead of ourselves.
There's a lot of work to be done before they'll be able to prove how effective it is. A small 12 person study is great for setting the stage for further research, but we've seen many times before with MSB is often hard replicating these findings in larger cohorts.
MSB Trading 2022, The TurnAround, page-563
-
- There are more pages in this discussion • 486 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2230 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.5¢ | 13189 | 1 |
View Market Depth
| Last trade - 09.32am 21/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable